BACKGROUND: Interaction of CD200 with its receptor CD200R has an immunoregulatory role and attenuates various types of neuroinflammatory diseases. METHODS: Immunofluorescence staining, western blot analysis, and RT-PCR were used to investigate the modulatory effects of CD200 fusion protein (CD200Fc) on activation of microglia and astrocytes as well as synthesis of pro- (TNF, IL-1β, IL-6) and anti-inflammatory (IL-4, IL-10) cytokines in the L4-L5 spinal cord segments in relation to behavioral signs of neuropathic pain after unilateral sterile chronic constriction injury (sCCI) of the sciatic nerve. Withdrawal thresholds for mechanical hypersensitivity and latencies for thermal hypersensitivity were measured in hind paws 1 day before operation; 1, 3, and 7 days after sCCI operation; and then 5 and 24 h after intrathecal application of artificial cerebrospinal fluid or CD200Fc. RESULTS: Seven days from sCCI operation and 5 h from intrathecal application, CD200Fc reduced mechanical and thermal hypersensitivity when compared with control animals. Simultaneously, CD200Fc attenuated activation of glial cells and decreased proinflammatory and increased anti-inflammatory cytokine messenger RNA (mRNA) levels. Administration of CD200Fc also diminished elevation of CD200 and CD200R proteins as a concomitant reaction of the modulatory system to increased neuroinflammatory reactions after nerve injury. The anti-inflammatory effect of CD200Fc dropped at 24 h after intrathecal application. CONCLUSIONS: Intrathecal administration of the CD200R1 agonist CD200Fc induces very rapid suppression of neuroinflammatory reactions associated with glial activation and neuropathic pain development. This may constitute a promising and novel therapeutic approach for the treatment of neuropathic pain.

Central European Institute of Technology Masaryk University Kamenice 3 62500 Brno Czech Republic

Department of Anatomy Division of Neuroanatomy Faculty of Medicine Masaryk University Kamenice 3 62500 Brno Czech Republic

Department of Functional and Systems Neurobiology Neuroimmunology Group Cajal Institute Consejo Superior de Investigaciones Científicas Madrid Spain

Zobrazit více v PubMed

Berger JV, Knaepen L, Janssen SPM, Jaken RJP, Marcus MAE, Joosten EAJ, et al. Cellular and molecular insights into neuropathy-induced pain hypersensitivity for mechanism-based treatment approaches. Brain Res Rev. 2011;67(1–2):282–310. doi: 10.1016/j.brainresrev.2011.03.003. PubMed DOI

Campbell JN, Meyer RA. Mechanisms of neuropathic pain. Neuron. 2006;52(1):77–92. doi: 10.1016/j.neuron.2006.09.021. PubMed DOI PMC

Marchand F, Perretti M, McMahon SB. Role of the immune system in chronic pain. Nature Rev Neurosci. 2005;6(7):521–32. doi: 10.1038/nrn1700. PubMed DOI

Watkins LR, Hutchinson MR, Ledeboer A, Wieseler-Frank J, Milligan ED, Maier SF. Glia as the “bad guys”: implications for improving clinical pain control and the clinical utility of opioids. Brain Behav Immun. 2007;21(2):131–46. doi: 10.1016/j.bbi.2006.10.011. PubMed DOI PMC

Swett JE, Torigoe Y, Elie VR, Bourassa CM, Miller PG. Sensory neurons of the rat sciatic-nerve. Exp Neurol. 1991;114(1):82–103. doi: 10.1016/0014-4886(91)90087-S. PubMed DOI

Klusakova I, Dubovy P. Experimental models of peripheral neuropathic pain based on traumatic nerve injuries—an anatomical perspective. Ann Anat. 2009;191(3):248–59. doi: 10.1016/j.aanat.2009.02.007. PubMed DOI

Moalem G, Tracey DJ. Immune and inflammatory mechanisms in neuropathic pain. Brain Res Rev. 2006;51(2):240–64. doi: 10.1016/j.brainresrev.2005.11.004. PubMed DOI

Choi H-S, Roh D-H, Yoon S-Y, Moon J-Y, Choi S-R, Kwon S-G, et al. Microglial interleukin-1 beta in the ipsilateral dorsal horn inhibits the development of mirror-image contralateral mechanical allodynia through astrocyte activation in a rat model of inflammatory pain. Pain. 2015;156(6):1046–59. PubMed

Gao YJ, Ji RR. Targeting astrocyte signaling for chronic pain. Neurotherapeutics. 2010;7(4):482–93. doi: 10.1016/j.nurt.2010.05.016. PubMed DOI PMC

Milligan ED, Twining C, Chacur M, Biedenkapp J, O’Connor K, Poole S, et al. Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats. J Neurosci. 2003;23(3):1026–40. PubMed PMC

Yamamoto Y, Terayama R, Kishimoto N, Maruhama K, Mizutani M, Iida S, et al. Activated microglia contribute to convergent nociceptive inputs to spinal dorsal horn neurons and the development of neuropathic pain. Neurochem Res. 2015;40(5):1000–12. doi: 10.1007/s11064-015-1555-8. PubMed DOI

Gao YJ, Ji RR. Chemokines, neuronal-glial interactions, and central processing of neuropathic pain. Pharmacol Ther. 2010;126(1):56–68. doi: 10.1016/j.pharmthera.2010.01.002. PubMed DOI PMC

Brazda V, Klusakova I, Svizenska IH, Dubovy P. Dynamic response to peripheral nerve injury detected by in situ hybridization of IL-6 and its receptor mRNAs in the dorsal root ganglia is not strictly correlated with signs of neuropathic pain. Mol Pain. 2013;9:42. doi: 10.1186/1744-8069-9-42. PubMed DOI PMC

Dubovy P, Brazda V, Klusakova I, Hradilova-Svizenska I. Bilateral elevation of interleukin-6 protein and mRNA in both lumbar and cervical dorsal root ganglia following unilateral chronic compression injury of the sciatic nerve. J Neuroinflamm. 2013;10:55. doi: 10.1186/1742-2094-10-55. PubMed DOI PMC

Hatashita S, Sekiguchi M, Kobayashi H, Konno SI, Kikuchi SI. Contralateral neuropathic pain and neuropathology in dorsal root ganglion and spinal cord following hemilateral nerve injury in rats. Spine. 2008;33(12):1344–51. doi: 10.1097/BRS.0b013e3181733188. PubMed DOI

Dubovy P. Wallerian degeneration and peripheral nerve conditions for both axonal regeneration and neuropathic pain induction. Ann Anat. 2011;194(4):267–75. doi: 10.1016/j.aanat.2011.02.011. PubMed DOI

Wright GJ, Cherwinski H, Foster-Cuevas M, Brooke G, Puklavec MJ, Bigler M, et al. Characterization of the CD200 receptor family in mice and humans and their interactions with CD200. J Immunol. 2003;171(6):3034–46. doi: 10.4049/jimmunol.171.6.3034. PubMed DOI

Hatherley D, Lea SM, Johnson S, Barclay AN. Structures of CD200/CD200 receptor family and implications for topology, regulation, and evolution. Structure. 2013;21(5):820–32. doi: 10.1016/j.str.2013.03.008. PubMed DOI PMC

Koning N, Bo L, Hoek RM, Huitinga I. Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions. Ann Neurol. 2007;62(5):504–14. doi: 10.1002/ana.21220. PubMed DOI

Dentesano G, Straccia M, Ejarque-Ortiz A, Tusell JM, Serratosa J, Saura J, et al. Inhibition of CD200R1 expression by C/EBP beta in reactive microglial cells. J Neuroinflamm. 2012;9:165. doi: 10.1186/1742-2094-9-165. PubMed DOI PMC

Dentesano G, Serratosa J, Tusell JM, Ramon P, Valente T, Saura J, et al. CD200R1 and CD200 expression are regulated by PPAR-gamma in activated glial cells. Glia. 2014;62(6):982–98. doi: 10.1002/glia.22656. PubMed DOI

Gao S, Hao B, Yang XF, Chen WQ. Decreased CD200R expression on monocyte-derived macrophages correlates with Th17/Treg imbalance and disease activity in rheumatoid arthritis patients. Inflamm Res. 2014;63(6):441–50. doi: 10.1007/s00011-014-0716-6. PubMed DOI

Koning N, Swaab DF, Hoek RM, Huitinga I. Distribution of the immune inhibitory molecules CD200 and CD200R in the normal central nervous system and multiple sclerosis lesions suggests neuron-glia and glia-glia interactions. J Neuropathol Exp Neurol. 2009;68(2):159–67. doi: 10.1097/NEN.0b013e3181964113. PubMed DOI

Costello DA, Lyons A, Denieffe S, Browne TC, Cox FF, Lynch MA. Long term potentiation is impaired in membrane glycoprotein CD200-deficient mice. A role for toll-like receptor activation. J Biol Chem. 2011;286(40):34722–32. doi: 10.1074/jbc.M111.280826. PubMed DOI PMC

Walker DG, Dalsing-Hernandez JE, Campbell NA, Lue LF. Decreased expression of CD200 and CD200 receptor in Alzheimer’s disease: a potential mechanism leading to chronic inflammation. Exp Neurol. 2009;215(1):5–19. doi: 10.1016/j.expneurol.2008.09.003. PubMed DOI PMC

Wang XJ, Ye M, Zhang YH, Chen SD. CD200-CD200R regulation of microglia activation in the pathogenesis of Parkinson’s disease. J Neuroimmun Pharmacol. 2007;2(3):259–64. doi: 10.1007/s11481-007-9075-1. PubMed DOI

Chitnis T, Imitola J, Wang Y, Elyaman W, Chawla P, Sharuk M, et al. Elevated neuronal expression of CD200 protects Wld(s) mice from inflammation-mediated neurodegeneration. Am J Pathol. 2007;170(5):1695–712. doi: 10.2353/ajpath.2007.060677. PubMed DOI PMC

Hoek RM, Ruuls SR, Murphy CA, Wright GJ, Goddard R, Zurawski SM, et al. Down-regulation of the macrophage lineage through interaction with OX2 (CD200) Science. 2000;290(5497):1768–71. doi: 10.1126/science.290.5497.1768. PubMed DOI

Meuth SG, Simon OJ, Gnimm A, Melzer N, Herrmann AM, Spitzer P, et al. CNS inflammation and neuronal degeneration is aggravated by impaired CD200-CD200R-mediated macrophage silencing. J Neuroimmunol. 2008;194(1–2):62–9. doi: 10.1016/j.jneuroim.2007.11.013. PubMed DOI

Lyons A, McQuillan K, Deighan BF, O’Reilly J-A, Downer EJ, Murphy AC, et al. Decreased neuronal CD200 expression in IL-4-deficient mice results in increased neuroinflammation in response to lipopolysaccharide. Brain Beh Immun. 2009;23(7):1020–7. doi: 10.1016/j.bbi.2009.05.060. PubMed DOI

Koning N, van Eijk M, Pouwels W, Brouwer MSM, Voehringer D, Huitinga I, et al. Expression of the inhibitory CD200 receptor is associated with alternative macrophage activation. J Innate Immun. 2010;2(2):195–200. doi: 10.1159/000252803. PubMed DOI

Cox FF, Carney D, Miller AM, Lynch MA. CD200 fusion protein decreases microglial activation in the hippocampus of aged rats. Brain Beh Immun. 2012;26(5):789–96. doi: 10.1016/j.bbi.2011.10.004. PubMed DOI

Hernangomez M, Mestre L, Correa FG, Loria F, Mecha M, Inigo PM, et al. CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation. Glia. 2012;60(9):1437–50. doi: 10.1002/glia.22366. PubMed DOI

Liu YR, Bando Y, Vargas-Lowy D, Elyaman W, Khoury SJ, Huang T, et al. CD200R1 agonist attenuates mechanisms of chronic disease in a murine model of multiple sclerosis. J Neurosci. 2010;30(6):2025–38. doi: 10.1523/JNEUROSCI.4272-09.2010. PubMed DOI PMC

Simelyte E, Criado G, Essex D, Uger RA, Feldmann M, Williams RO. CD200-Fc, a novel antiarthritic biologic agent that targets proinflammatory cytokine expression in the joints of mice with collagen-induced arthritis. Arthritis Rheum. 2008;58(4):1038–43. doi: 10.1002/art.23378. PubMed DOI

Ding Y, Yang H, Xiang W, He X, Liao W, Yi Z. CD200R1 agonist attenuates LPS-induced inflammatory response in human renal proximal tubular epithelial cells by regulating TLR4-MyD88-TAK1-mediated NF-kappa B and MAPK pathway. Biochem Biophys Res Comm. 2015;460(2):287–94. doi: 10.1016/j.bbrc.2015.03.026. PubMed DOI

Hylden JLK, Wilcox GL. Intrathecal morphine in mice—a new technique. Eur J Pharmacol. 1980;67(2–3):313–6. doi: 10.1016/0014-2999(80)90515-4. PubMed DOI

Zamboni L, Demartin C. Buffered picric acid-formaldehyde—a new rapid fixative for electron microscopy. J Cell Biol. 1967;35(2P2):A148.

Brazda V, Muller P, Brozkova K, Vojtesek B. Restoring wild-type conformation and DNA-binding activity of mutant p53 is insufficient for restoration of transcriptional activity. Biochem Biophys Res Comm. 2006;351(2):499–506. doi: 10.1016/j.bbrc.2006.10.065. PubMed DOI

Ren Y, Yang B, Yin Y, Leng X, Jiang Y, Zhang L, et al. Aberrant CD200/CD200R1 expression and its potential role in Th17 cell differentiation, chemotaxis and osteoclastogenesis in rheumatoid arthritis. Rheumatology. 2015;54(4):712–21. doi: 10.1093/rheumatology/keu362. PubMed DOI

Austin PJ, Moalem-Taylor G. Animal models of neuropathic pain due to nerve injury. Neuromethods. 2013;78:239–60. doi: 10.1007/978-1-62703-233-9_14. DOI

Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 1988;33(1):87–107. doi: 10.1016/0304-3959(88)90209-6. PubMed DOI

Maves TJ, Pechman PS, Gebhart GF, Meller ST. Possible chemical contribution from chromic gut sutures produces disorders of pain sensation like those seen in man. Pain. 1993;54(1):57–69. doi: 10.1016/0304-3959(93)90100-4. PubMed DOI

Pineau I, Lacroix S. Endogenous signals initiating inflammation in the injured nervous system. Glia. 2009;57(4):351–61. doi: 10.1002/glia.20763. PubMed DOI

Guo W, Wang H, Watanabe M, Shimizu K, Zou SP, LaGraize SC, et al. Glial-cytokine-neuronal interactions underlying the mechanisms of persistent pain. J Neurosci. 2007;27(22):6006–18. doi: 10.1523/JNEUROSCI.0176-07.2007. PubMed DOI PMC

Clark AK, Yip PK, Grist J, Gentry C, Staniland AA, Marchand F, et al. Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain. Proc Natl Acad Sci U S A. 2007;104(25):10655–60. doi: 10.1073/pnas.0610811104. PubMed DOI PMC

Raghavendra V, Tanga F, DeLeo JA. Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. J Pharmacol Exp Ther. 2003;306(2):624–30. doi: 10.1124/jpet.103.052407. PubMed DOI

Gorczynski RM, Cattral MS, Chen ZG, Hu JA, Lei J, Min WP, et al. An immunoadhesin incorporating the molecule OX-2 is a potent immunosuppressant that prolongs allo- and xenograft survival. J Immunol. 1999;163(3):1654–60. PubMed

Wang W, Mei XP, Huang J, Wei YY, Wang YY, Wu SX, et al. Crosstalk between spinal astrocytes and neurons in nerve injury-induced neuropathic pain. Plos One. 2009;4(9):10. PubMed PMC

Padi SSV, Kulkarni SK. Minocycline prevents the development of neuropathic pain, but not acute pain: possible anti-inflammatory and antioxidant mechanisms. Eur J Pharmacol. 2008;601(1–3):79–87. doi: 10.1016/j.ejphar.2008.10.018. PubMed DOI

Morioka N, Zhang FF, Nakamura Y, Kitamura T, Hisaoka-Nakashima K, Nakata Y. Tumor necrosis factor-mediated downregulation of spinal astrocytic connexin43 leads to increased glutamatergic neurotransmission and neuropathic pain in mice. Brain Beh Immun. 2015;49:293–310. doi: 10.1016/j.bbi.2015.06.015. PubMed DOI

Beggs S, Salter MW. Stereological and somatotopic analysis of the spinal microglial response to peripheral nerve injury. Brain Beh Immun. 2007;21(5):624–33. doi: 10.1016/j.bbi.2006.10.017. PubMed DOI PMC

Blackbeard J, O’Dea KP, Wallace VCJ, Segerdahl A, Pheby T, Takata M, et al. Quantification of the rat spinal microglial response to peripheral nerve injury as revealed by immunohistochemical image analysis and flow cytometry. J Neurosci Meth. 2007;164(2):207–17. doi: 10.1016/j.jneumeth.2007.04.013. PubMed DOI PMC

Ji RR, Berta T, Nedergaard M. Glia and pain: is chronic pain a gliopathy? Pain. 2013;154:S10–28. doi: 10.1016/j.pain.2013.06.022. PubMed DOI PMC

Mika J, Osikowicz M, Rojewska E, Korostynski M, Wawrzczak-Bargiela A, Przewlocki R, et al. Differential activation of spinal microglial and astroglial cells in a mouse model of peripheral neuropathic pain. Eur J Pharmacol. 2009;623(1–3):65–72. doi: 10.1016/j.ejphar.2009.09.030. PubMed DOI

Lyons A, Downer EJ, Crotty S, Nolan YM, Mills KHG, Lynch MA. CD200 ligand-receptor interaction modulates microglial activation in vivo and in vitro: a role for IL-4. J Neurosci. 2007;27(31):8309–13. doi: 10.1523/JNEUROSCI.1781-07.2007. PubMed DOI PMC

Cregg JM, DePaul MA, Filous AR, Lang BT, Tran A, Silver J. Functional regeneration beyond the glial scar. Exp Neurol. 2014;253:197–207. doi: 10.1016/j.expneurol.2013.12.024. PubMed DOI PMC

Nolte C, Matyash M, Pivneva T, Schipke CG, Ohlemeyer C, Hanisch UK, et al. GFAP promoter-controlled EGFP-expressing transgenic mice: a tool to visualize astrocytes and astrogliosis in living brain tissue. Glia. 2001;33(1):72–86. doi: 10.1002/1098-1136(20010101)33:1<72::AID-GLIA1007>3.0.CO;2-A. PubMed DOI

Lan L, Yuan H, Duan L, Cao R, Gao B, Shen J, et al. Blocking the glial function suppresses subcutaneous formalin-induced nociceptive behavior in the rat. Neurosci Res. 2007;57(1):112–9. doi: 10.1016/j.neures.2006.09.014. PubMed DOI

Mika J, Zychowska M, Popiolek-Barczyk K, Rojewska E, Przewlocka B. Importance of glial activation in neuropathic pain. Eur J Pharmacol. 2013;716(1–3):106–19. doi: 10.1016/j.ejphar.2013.01.072. PubMed DOI

Feng XM, Zhang FJ, Dong R, Li WY, Liu J, Zhao X, et al. Intrathecal administration of clonidine attenuates spinal neuroimmune activation in a rat model of neuropathic pain with existing hyperalgesia. Eur J Pharmacol. 2009;614(1–3):38–43. doi: 10.1016/j.ejphar.2009.04.044. PubMed DOI

Kersten C, Cameron MG, Laird B, Mjaland S. Epidermal growth factor receptor—inhibition (EGFR-I) in the treatment of neuropathic pain. Br J Anaesth. 2015;115(5):761–7. doi: 10.1093/bja/aev326. PubMed DOI

Xin Q, Cheng B, Pan Y, Liu H, Yang C, Chen J, et al. Neuroprotective effects of apelin-13 on experimental ischemic stroke through suppression of inflammation. Peptides. 2015;63:55–62. doi: 10.1016/j.peptides.2014.09.016. PubMed DOI

Zhang S, Wang XJ, Tian LP, Pan J, Lu GQ, Zhang YJ, et al. CD200-CD200R dysfunction exacerbates microglial activation and dopaminergic neurodegeneration in a rat model of Parkinson’s disease. J Neuroinflamm. 2011;8:154. doi: 10.1186/1742-2094-8-154. PubMed DOI PMC

Narita M, Yoshida T, Nakajima M, Narita M, Miyatake M, Takagi T, et al. Direct evidence for spinal cord microglia in the development of a neuropathic pain-like state in mice. J Neurochem. 2006;97(5):1337–48. doi: 10.1111/j.1471-4159.2006.03808.x. PubMed DOI

Kleinschnitz C, Brinkhoff J, Sommer C, Stoll G. Contralateral cytokine gene induction after peripheral nerve lesions: dependence on the mode of injury and NMDA receptor signaling. Mol Brain Res. 2005;136(1–2):23–8. doi: 10.1016/j.molbrainres.2004.12.015. PubMed DOI

Latremoliere A, Mauborgne A, Masson J, Bourgoin S, Kayser V, Hamon M, et al. Differential implication of proinflammatory cytokine interleukin-6 in the development of cephalic versus extracephalic neuropathic pain in rats. J Neurosci. 2008;28(34):8489–501. doi: 10.1523/JNEUROSCI.2552-08.2008. PubMed DOI PMC

Uceyler N, Tscharke A, Sommer C. Early cytokine gene expression in mouse CNS after peripheral nerve lesion. Neurosci Lett. 2008;436(2):259–64. doi: 10.1016/j.neulet.2008.03.037. PubMed DOI

Sacerdote P, Franchi S, Moretti S, Castelli M, Procacci P, Magnaghi V, et al. Cytokine modulation is necessary for efficacious treatment of experimental neuropathic pain. J Neuroimmun Pharmacol. 2013;8(1):202–11. doi: 10.1007/s11481-012-9428-2. PubMed DOI

Wilkerson JL, Gentry KR, Dengler EC, Wallace JA, Kerwin AA, Armijo LM, et al. Intrathecal cannabilactone CB2R agonist, AM1710, controls pathological pain and restores basal cytokine levels. Pain. 2012;153(5):1091–106. doi: 10.1016/j.pain.2012.02.015. PubMed DOI PMC

Milligan ED, Sloane EM, Langer SJ, Cruz PE, Chacur M, Spataro L, et al. Controlling neuropathic pain by adeno-associated virus driven production of the anti-inflammatory cytokine, interleukin-10. Mol Pain. 2005;1:9. doi: 10.1186/1744-8069-1-9. PubMed DOI PMC

Uceyler N, Topuzoglu T, Schiesser P, Hahnenkamp S, Sommer C. IL-4 deficiency is associated with mechanical hypersensitivity in mice. Plos One. 2011;6(12):e28205. doi: 10.1371/journal.pone.0028205. PubMed DOI PMC

Lyons A, Downer EJ, Costello DA, Murphy N, Lynch MA. Dok2 mediates the CD200Fc attenuation of A beta-induced changes in glia. J Neuroinflamm. 2012;9:107. doi: 10.1186/1742-2094-9-107. PubMed DOI PMC

Cox FF, Berezin V, Bock E, Lynch MA. The neural cell adhesion molecule-derived peptide, FGL, attenuates lipopolysaccharide-induced changes in glia in a cd200-dependent manner. Neurosci. 2013;235:141–8. doi: 10.1016/j.neuroscience.2012.12.030. PubMed DOI

Inflammatory changes in the choroid plexus following subarachnoid hemorrhage: the role of innate immune receptors and inflammatory molecules

Specialized Pro-Resolving Lipid Mediators: The Future of Chronic Pain Therapy?

Subarachnoid Hemorrhage Increases Level of Heme Oxygenase-1 and Biliverdin Reductase in the Choroid Plexus

Subarachnoid Hemorrhage Induces Dynamic Immune Cell Reactions in the Choroid Plexus